BANGKOK (Reuters) - A Thai court has ordered a leading government foe to remove allegations on social media that the state's coronavirus vaccine policy is opaque and unfairly favours a company owned ...
BANGKOK (Reuters) - Thai drugmaker Siam Bioscience, owned by the country's king, reported a near 50-fold increase in annual profit in 2021, when it began producing AstraZeneca Plc's COVID-19 vaccine, ...
Bristol, UK and Bangkok, Thailand, 23 rd September - eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Siam Bioscience, a leading biopharmaceutical ...
MANILA, June 1 (Reuters) - Delivery to the Philippines of the first batches of a promised 17 million doses of Thai-made AstraZeneca (AZN.L), opens new tab vaccines has been delayed by several weeks ...
Thailand began its mass Covid vaccination program Monday, following criticism of delays and concerns over health authorities relying on AstraZeneca shots produced by a company owned by the country’s ...
BANGKOK, July 15 (Reuters) - AstraZeneca (AZN.L), opens new tab is seeking to delay delivery of 61 million doses of its COVID-19 vaccines to Thailand by five months, a Thai official said Thursday, as ...
eXmoor Pharma and Siam Bioscience, announced a strategic partnership to build the region’s foremost centre for Cell and Gene Therapy (CGT) development and manufacturing. The collaboration aims to ...
MANILA, June 1 (Reuters) - Delivery to the Philippines of the first batches of a promised 17 million doses of Thai-made AstraZeneca AZN.L vaccines has been delayed by several weeks and reduced in size ...
Thailand began its mass Covid vaccination program Monday, following criticism of delays and concerns over health authorities relying on AstraZeneca shots produced by a company owned by the country’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback